DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on

Size: px
Start display at page:

Download "DCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on"

Transcription

1 DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on

2 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical Research 2

3 What is ADaM? Datasets created to support analyses analysis-ready Rich with metadata support DEFINE file Computational methods document/reviewer s guide Results-metadata also a component Elements for DEFINE identified DEFINE schema does not yet support Can be produced in non-xml fashion 3

4 ADaM vs SDTM We know in CDISC there is SDTM and ADaM Some think of SDTM as collected data and ADaM as analysis/derived data Distinction not 100% accurate and lines may get more blurred over time SDTM has many derived components AGE (unless collected on CRF) RFSTDTC/RFENDTC --DY (study day anchored by RFSTDTC) Patient Populations (SUPPDM) Rows added with DRVFL=Y (total score in QS) 4

5 Why Not Just Use SDTM? Components not gathered in one place Populations Treatment values Values from multiple domains (AEs by baseline APACHE score) Fixed and Rigid Structure Does not allow addition of supportive variables Does not allow for all transformations of values (categorization (RESCAT has been added but only allows one ), groupings, etc.) Unless SUPP is used as primary storage space However - Additions in SUPPs which are not 100% user-friendly Not a lot of controlled terminology huge learning curve Values can only be captured as character and not numeric No standard tools to put things together 5

6 Why Not Just Use SDTM? (cont.) Analysis Components not part of standard Visit windows Record selection flags Derivation methodology captured as free text Supportive variables have to be supp ed Metadata for SUPPs are not user-friendly 6

7 Simple Summary From SDTM Age Univariate by Treatment Group Safety Population Age from DM Treatment Group ARM from DM QNAM=SAFETY, QVAL=Y from SUPPDM Easy to create and reproduce if standard tool is available to put DM and SUPPDM together 7

8 Less Simple Summary From SDTM Disposition by Treatment Group Safety Population Completion Status from DS Treatment Group ARM from DM QNAM=SAFETY, QVAL=Y from SUPPDM Requires: Subsetting of DS records Merge of DM/SUPPDM Merge of DS and DM Assumes all subjects have a disposition record does not account for ongoing subjects 8

9 Slightly Complicated Summary From SDTM Vital Signs Summary by Analysis Visit and Treatment Group Vital Sign Values from VS Treatment Group ARM from DM QNAM=SAFETY, QVAL=Y from SUPPDM Requires: Windowing of VS records per SAP Data or metadata to support windowing decisions Selection decision if more than one record in window Merge of DM/SUPPDM Merge of VS and DM 9

10 So Now What? We ADaM! Decide which ADaM datasets to create Gather source data Gather source documentation Create specifications Create ADaM datasets QC datasets Create DEFINE (.doc,.pdf,.xml,html depending on requirements) Outputs and documentation we will leave for another time 10

11 SDTM/ADaM Relationship How do they interact? Creation Process SDTM -> ADaM ADaM Superdataset -> SDTM and ADaM ADaM -> SDTM Documentation ADaM has to point back to SDTM Reconstruction/consistency is an issue that has to be considered 11

12 Which ADaM Datatsets Do I Create? ADSL required Anything more is up to sponsor and reviewer ADaM Model Document: consist of the optimum number of analysis datasets needed and have enough self-sufficiency to allow analysis and review with little or no additional programming or data processing " Some possibilities: Support only selected summaries Key safety and efficacy Support all summaries Support all outputs 12

13 Where Does ADaM Come From? Source data and documentation: ADaM Model has ADaM datasets built from SDTM domains as the default methodology Even if SDTM is not source for ADaM, ADaM metadata has to indicate how to create ADaM from SDTM External input: Data that may not be captured in SDTM (dictionaries, IVRS variables, Evaluation Committee data) Decision spreadsheets Disallowed medications Sponsor over-rides 13

14 Where Does ADaM Come From? (cont.) Documents: Protocol SAP Table shells Evaluability plan (definitions for populations and end-point determinations with supportive review outputs) SDTM define 14

15 Analysis Dataset Specifications Everyone has their own methodology One method is to create excel spreadsheets Provides a priori direction Dataset/variable names attributes algorithms Captures post facto documentation Special rules implemented during dataset creation Decision spreadsheet values, etc. Can be used as input into Define creation Populate source/derivation column Provide content for computational method document 15

16 What Goes Into ADaM? ADSL Subject level population flags Planned and actual treatment variables Demographic information Randomization factors Subgrouping variables Important dates 16

17 What Goes Into ADaM? (cont.) BDS (Basic Data Structure) PARAM/PARAMCD (required) AVAL/AVALC (at least one is required) other analysis variables (CHG, AVALCAT1) by group variables (AGEGRP1, SEX) Selection flags (ITTRFL, ANL01FL) Treatment variables (TRTP, TRTA) Can be grouped by topic Labs, vitals, time-to-event parameters 17

18 More ADaMs Standards: ADAE post-public review ADTTE post-public review Some other possibilities: ADEFF ADLB ADRESP No current controlled terminology (besides for ADSL) 18

19 How Do You Evaluate ADaM Datasets? Fundamental Principles : Analysis datasets and their associated metadata must: facilitate clear and unambiguous communication provide traceability between the analysis data and its source data (ultimately SDTM) be readily useable by commonly available software tools Analysis datasets must: be accompanied by metadata be analysis-ready 19

20 How Do You Evaluate ADaM Datasets? Some principles are testable and some are not Does data and metadata allow a user to reproduce the results? Does data comply to the standard? ~180 checks defined to measure compliance Metadata for ADaM does not currently fit into define schema (parameter identifier and results metadata) Define.xml for ADaM can be created using SDTM schema but is not required 20

21 How Do You Document ADaM Databases? ADaM Metadata Dataset metadata Variable metadata Parameter-level metadata Results level metadata 21

22 Dataset Metadata 22

23 Dataset Metadata example 23

24 Variable Metadata 24

25 Variable Metadata example 25

26 Parameter-Level Metadata 26

27 Results Level Metadata 27

28 28

29 Results Level Metadata example 29

30 Does Anything From ADaM Go Back Into SDTM? Patient Populations Can go seamlessly from ADSL into SUPPDM Allows for the creators to create and the users to use Input into population creation needs a process and is a subject for another day Complicated Endpoint Values Capturing in ADaM only means it is not available with SDTM data Capturing as an SDTM data fact is possible but traceability/documentation becomes a hunting exercise Very careful process has to be followed to ensure linear process and no circular logic is followed 30

31 What Next? Posted Compliance checks 180 checks OpenCDISC has created ADaM Validator ADAE Draft posted >450 comments received ADTTE Draft posted >150 comments received Near future General Examples Metadata 31

32 Questions? Thank you all for attending!! 32

33 Source material: ADaM Model Document V2.1 ADAMIG V1.0 33

Introduction to ADaM and What s new in ADaM

Introduction to ADaM and What s new in ADaM Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis

More information

How to write ADaM specifications like a ninja.

How to write ADaM specifications like a ninja. Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation

More information

An Efficient Solution to Efficacy ADaM Design and Implementation

An Efficient Solution to Efficacy ADaM Design and Implementation PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,

More information

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...

From Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments... From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC

More information

Implementing CDISC Using SAS. Full book available for purchase here.

Implementing CDISC Using SAS. Full book available for purchase here. Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models

More information

ADaM Reviewer s Guide Interpretation and Implementation

ADaM Reviewer s Guide Interpretation and Implementation Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about

More information

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting

More information

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.

Automate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc. Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o

More information

Robust approach to create Define.xml v2.0. Vineet Jain

Robust approach to create Define.xml v2.0. Vineet Jain Robust approach to create Define.xml v2.0 Vineet Jain DEFINE SYSTEM GOALS Generic Powerful Reliable Integrable Efficient Works across SDTM, ADaM & SEND Create define.xml, annotated CRF & define.pdf Create

More information

Some Considerations When Designing ADaM Datasets

Some Considerations When Designing ADaM Datasets Some Considerations When Designing ADaM Datasets Italian CDISC UN Day - Milan 27 th October 2017 Antonio Valenti Principal Statistical Programmer CROS NT - Verona Content Disclaimer All content included

More information

Introduction to ADaM standards

Introduction to ADaM standards Introduction to ADaM standards Elke Sennewald, Director Biostatistics EU/AP, 06 March 2009 1 Outline ADaM Version 2.0 / 2.1 General Considerations ADaM draft Version 2.1 ADaMIG draft Version 1.0 ADaM Variables

More information

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!

Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! 1 Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of

More information

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting

CDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.

More information

ADaM Compliance Starts with ADaM Specifications

ADaM Compliance Starts with ADaM Specifications PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new

More information

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA

The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis

More information

Material covered in the Dec 2014 FDA Binding Guidances

Material covered in the Dec 2014 FDA Binding Guidances Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material

More information

Programming checks: Reviewing the overall quality of the deliverables without parallel programming

Programming checks: Reviewing the overall quality of the deliverables without parallel programming PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,

More information

Creating an ADaM Data Set for Correlation Analyses

Creating an ADaM Data Set for Correlation Analyses PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships

More information

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team

Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is version 1.1 and corresponds to Version 2.1 of the

More information

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES

ABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES Developing Integrated Summary of Safety Database using CDISC Standards Rajkumar Sharma, Genentech Inc., A member of the Roche Group, South San Francisco, CA ABSTRACT Most individual trials are not powered

More information

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE

AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AGENDA 1. Motivation 2. Automation Overview 3. Architecture 4. Validating the System 5. Pilot Study Results 6. Future State Copyright 2012-2017

More information

Dealing with changing versions of SDTM and Controlled Terminology (CT)

Dealing with changing versions of SDTM and Controlled Terminology (CT) CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards

More information

PharmaSUG Paper PO22

PharmaSUG Paper PO22 PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT

More information

PharmaSUG Paper PO21

PharmaSUG Paper PO21 PharmaSUG 2015 - Paper PO21 Evaluating SDTM SUPP Domain For AdaM - Trash Can Or Buried Treasure Xiaopeng Li, Celerion, Lincoln, NE Yi Liu, Celerion, Lincoln, NE Chun Feng, Celerion, Lincoln, NE ABSTRACT

More information

Updates on CDISC Standards Validation

Updates on CDISC Standards Validation Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation

More information

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method

The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT

More information

Considerations on creation of SDTM datasets for extended studies

Considerations on creation of SDTM datasets for extended studies 13/May/2016 As one of the activities of CDISC Japan User Group (CJUG), a small group, "Extension study team" was organized in 2015. The team discussed what kind of approach works better for SDTM creation

More information

NCI/CDISC or User Specified CT

NCI/CDISC or User Specified CT NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or

More information

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples

Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT

More information

Legacy to SDTM Conversion Workshop: Tools and Techniques

Legacy to SDTM Conversion Workshop: Tools and Techniques Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often

More information

Study Data Reviewer s Guide Completion Guideline

Study Data Reviewer s Guide Completion Guideline Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on

More information

ADaM Implementation Guide Prepared by the CDISC ADaM Team

ADaM Implementation Guide Prepared by the CDISC ADaM Team 1 2 3 ADaM Implementation Guide Prepared by the CDISC ADaM Team 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Revision History Notes to Readers Date Version Summary of Changes May 30, 2008 1.0 Draft

More information

Traceability Look for the source of your analysis results

Traceability Look for the source of your analysis results Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,

More information

PharmaSUG Paper DS24

PharmaSUG Paper DS24 PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,

More information

Riepilogo e Spazio Q&A

Riepilogo e Spazio Q&A Riepilogo e Spazio Q&A CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda ADaM key list Bad & Good ADaM...More... Spazio Q&A ADaM Key List

More information

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0

It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges

More information

Customer oriented CDISC implementation

Customer oriented CDISC implementation Paper CD10 Customer oriented CDISC implementation Edelbert Arnold, Accovion GmbH, Eschborn, Germany Ulrike Plank, Accovion GmbH, Eschborn, Germany ABSTRACT The Clinical Data Interchange Standards Consortium

More information

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA

PharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort

More information

ADaM and traceability: Chiesi experience

ADaM and traceability: Chiesi experience ADaM and traceability: Chiesi experience BIAS Seminar «Data handling and reporting in clinical trials with SAS» Glauco Cappellini 22-Feb-2013 Agenda Chiesi Model for Biometrics Regulatory Background ADaM:

More information

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA

Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA ABSTRACT PharmaSUG 2013 - Paper PO13 Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA Traceability is one of the fundamentals of the ADaM Standard. However, there is not

More information

ADaM Implementation Guide Status Update

ADaM Implementation Guide Status Update ADaM Implementation Guide Status Update John K. Troxell John Troxell Consulting LLC Bridgewater, NJ jktroxell@gmail.com June 17, 2013 Current CDISC ADaM Documents 2009 Analysis Data Model (ADaM), Version

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis

More information

OpenCDISC Validator 1.4 What s New?

OpenCDISC Validator 1.4 What s New? OpenCDISC Validator 1.4 What s New? Bay Area CDISC Implementation Network 23 May 2013 David Borbas Sr Director, Data Management Jazz Pharmaceuticals, Inc. Disclaimers The opinions expressed in this presentation

More information

Lex Jansen Octagon Research Solutions, Inc.

Lex Jansen Octagon Research Solutions, Inc. Converting the define.xml to a Relational Database to enable Printing and Validation Lex Jansen Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D PhUSE 2009, Basel,

More information

Why organizations need MDR system to manage clinical metadata?

Why organizations need MDR system to manage clinical metadata? PharmaSUG 2018 - Paper SS-17 Why organizations need MDR system to manage clinical metadata? Abhinav Jain, Ephicacy Consulting Group Inc. ABSTRACT In the last decade, CDISC standards undoubtedly have transformed

More information

ADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter

ADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter ADaM IG v1.1 & ADaM OCCDS v1.0 Dr. Silke Hochstaedter 1 Agenda What s new in Analysis Data Model Implementation Guide Version 1.1 The new ADaM Structure for Occurrence Data (OCCDS) Version 1.0 Q&A ADaM

More information

ADaM for Medical Devices: Extending the Current ADaM Structures

ADaM for Medical Devices: Extending the Current ADaM Structures PharmaSUG 2018 - Paper MD-02 ADaM for Medical s: Extending the Current ADaM Structures Sandra Minjoe, PRA Health Sciences; Julia Yang, Medtronic PLC; Priya Gopal, TESARO, Inc. ABSTRACT The current ADaM

More information

Metadata and ADaM.

Metadata and ADaM. Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata

More information

Deriving Rows in CDISC ADaM BDS Datasets

Deriving Rows in CDISC ADaM BDS Datasets ABSTRACT PharmaSUG 2017 Paper DS22 Deriving Rows in CDISC ADaM BDS Datasets Sandra Minjoe, Accenture Accelerated R&D Services The ADaM Basic Data Structure (BDS) can be used for many analysis needs, including

More information

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania

Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data

More information

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI

From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI PharmaSUG2011 - Paper HW05 From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI ABSTRACT You've just read through the protocol,

More information

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams

CDASH MODEL 1.0 AND CDASHIG 2.0. Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams CDASH MODEL 1.0 AND CDASHIG 2.0 Kathleen Mellars Special Thanks to the CDASH Model and CDASHIG Teams 1 What is CDASH? Clinical Data Acquisition Standards Harmonization (CDASH) Standards for the collection

More information

Now let s take a look

Now let s take a look 1 2 3 4 Manage assets across the end to end life cycle of your studies This includes forms, datasets, terminologies, files, links and more, for example: - Studies may contain the protocol, a set of Forms,

More information

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD

Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM. Ajay Gupta, PPD Advanced Data Visualization using TIBCO Spotfire and SAS using SDTM Ajay Gupta, PPD INTRODUCTION + TIBCO Spotfire is an analytics and business intelligence platform, which enables data visualization in

More information

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission

Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the

More information

DIA 11234: CDER Data Standards Common Issues Document webinar questions

DIA 11234: CDER Data Standards Common Issues Document webinar questions Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect

More information

A Taste of SDTM in Real Time

A Taste of SDTM in Real Time A Taste of SDTM in Real Time Changhong Shi, Merck & Co., Inc., Rahway, NJ Beilei Xu, Merck & Co., Inc., Rahway, NJ ABSTRACT The Study Data Tabulation Model (SDTM) is a Clinical Data Interchange Standards

More information

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1

Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 PharmaSUG 2017 - Paper DS18 Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 John Troxell, Accenture ABSTRACT Since the publication of version 1.0 of the CDISC (Clinical Data Interchange

More information

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes

PharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA

More information

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation

How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Paper DH05 How a Metadata Repository enables dynamism and automation in SDTM-like dataset generation Judith Goud, Akana, Bennekom, The Netherlands Priya Shetty, Intelent, Princeton, USA ABSTRACT The traditional

More information

TS04. Running OpenCDISC from SAS. Mark Crangle

TS04. Running OpenCDISC from SAS. Mark Crangle TS04 Running OpenCDISC from SAS Mark Crangle Introduction The OpenCDISC validator is a tool used to check the compliance of datasets with CDISC standards Open-source Freely available and created by team

More information

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA

Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA Paper DH06 Automated Creation of Submission-Ready Artifacts Silas McKee, Accenture, Pennsylvania, USA Lourdes Devenney, Accenture, Pennsylvania, USA ABSTRACT Despite significant progress towards the standardization

More information

Challenges with the interpreta/on of CDISC - Who can we trust?

Challenges with the interpreta/on of CDISC - Who can we trust? Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle

More information

Application of SDTM Trial Design at GSK. 9 th of December 2010

Application of SDTM Trial Design at GSK. 9 th of December 2010 Application of SDTM Trial Design at GSK Veronica Martin Veronica Martin 9 th of December 2010 Contents SDTM Trial Design Model Ti Trial ldesign datasets t Excel Template for Trial Design 2 SDTM Trial Design

More information

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets

Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets PharmaSUG2011 Paper CD17 Making a List, Checking it Twice (Part 1): Techniques for Specifying and Validating Analysis Datasets Elizabeth Li, PharmaStat LLC, Newark, California Linda Collins, PharmaStat

More information

CDISC SDTM and ADaM Real World Issues

CDISC SDTM and ADaM Real World Issues CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC

More information

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Paper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA Paper FC02 SDTM, Plus or Minus Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT The CDISC Study Data Tabulation Model (SDTM) has become the industry standard for the regulatory submission

More information

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development

Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.

More information

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit

Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Creating Define-XML version 2 including Analysis Results Metadata with the SAS Clinical Standards Toolkit Lex Jansen Principal Software Developer @ SAS PharmaSUG 2016 Agenda Why Analysis Results Metadata?

More information

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC

Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard

More information

Common Programming Errors in CDISC Data

Common Programming Errors in CDISC Data ABSTRACT PharmaSUG 2017 - Paper DS15 Common Programming Errors in CDISC Data Sergiy Sirichenko, Pinnacle 21 Data in standardized format is now a required part of regulatory submissions. CDISC standards

More information

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library

Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies

More information

Interpreting CDISC ADaM IG through Users Interpretation

Interpreting CDISC ADaM IG through Users Interpretation Paper CD01 Interpreting CDISC ADaM IG through Users Interpretation Angelo Tinazzi, Cytel Inc., Geneva, Switzerland ABSTRACT It is now almost three years CDISC ADaM is an official standard the pharmaceutical

More information

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6

SDTM-ETL TM. New features in version 1.6. Author: Jozef Aerts XML4Pharma July SDTM-ETL TM : New features in v.1.6 SDTM-ETL TM New features in version 1.6 Author: Jozef Aerts XML4Pharma July 2011 p.1/14 Table of Contents Implementation of SEND v.3.0 final...3 Automated creation of the RELREC dataset and records...4

More information

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database

Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM

More information

SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC

SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC PharmaSUG 2016 - Paper PO21 SDTM Automation with Standard CRF Pages Taylor Markway, SCRI Development Innovations, Carrboro, NC ABSTRACT Much has been written about automatically creating outputs for the

More information

PharmaSUG2014 Paper DS09

PharmaSUG2014 Paper DS09 PharmaSUG2014 Paper DS09 An ADaM Interim Dataset for Time-to-Event Analysis Needs Tom Santopoli, Accenture, Berwyn, PA Kim Minkalis, Accenture, Berwyn, PA Sandra Minjoe, Accenture, Berwyn, PA ABSTRACT

More information

Applying ADaM Principles in Developing a Response Analysis Dataset

Applying ADaM Principles in Developing a Response Analysis Dataset PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium

More information

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England

PhUSE EU Connect Paper PP15. Stop Copying CDISC Standards. Craig Parry, SyneQuaNon, Diss, England Paper PP15 Abstract Stop Copying CDISC Standards Craig Parry, SyneQuaNon, Diss, England We repeatedly see repositories which require a large amount of front loading, a lot of duplicating of the Clinical

More information

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components

SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT

More information

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA

Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex

More information

Advanced Visualization using TIBCO Spotfire and SAS

Advanced Visualization using TIBCO Spotfire and SAS PharmaSUG 2018 - Paper DV-04 ABSTRACT Advanced Visualization using TIBCO Spotfire and SAS Ajay Gupta, PPD, Morrisville, USA In Pharmaceuticals/CRO industries, you may receive requests from stakeholders

More information

Clinical Metadata Metadata management with a CDISC mindset

Clinical Metadata Metadata management with a CDISC mindset Paper SI02 Clinical Metadata Metadata management with a CDISC mindset Andrew Ndikom, Clinical Metadata, London, United Kingdom Liang Wang, Clinical Metadata, London, United Kingdom ABSTRACT Metadata is

More information

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA

Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA PharmaSUG 2016 - Paper SS12 Submission-Ready Define.xml Files Using SAS Clinical Data Integration Melissa R. Martinez, SAS Institute, Cary, NC USA ABSTRACT SAS Clinical Data Integration simplifies the

More information

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit

Pooling Clinical Data: Key points and Pitfalls. October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Pooling Clinical Data: Key points and Pitfalls October 16, 2012 Phuse 2012 conference, Budapest Florence Buchheit Introduction Are there any pre-defined rules to pool clinical data? Are there any pre-defined

More information

Standardising The Standards The Benefits of Consistency

Standardising The Standards The Benefits of Consistency Paper DH06 Standardising The Standards The Benefits of Consistency Nathan James, Roche Products Ltd., Welwyn Garden City, UK ABSTRACT The introduction of the Study Data Tabulation Model (SDTM) has had

More information

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA

Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA PharmaSug2016- Paper HA03 Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA ABSTRACT A composite endpoint in a Randomized Clinical Trial

More information

Pooling Clinical Data: Key points and Pitfalls

Pooling Clinical Data: Key points and Pitfalls Paper DH01 Pooling Clinical Data: Key points and Pitfalls Florence Buchheit, Novartis, Basel, Switzerland ABSTRACT Pooling of clinical data is used by all Pharmaceutical companies. Submission to Health

More information

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards

SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched

More information

Harnessing the Web to Streamline Statistical Programming Processes

Harnessing the Web to Streamline Statistical Programming Processes Paper TT03 Harnessing the Web to Streamline Statistical Programming Processes Daniel Boisvert, Biogen, Cambridge MA, USA Pankaj Kumar, Biogen, Cambridge MA, USA Gordon Schantz, Biogen, Cambridge MA, USA

More information

Standardizing FDA Data to Improve Success in Pediatric Drug Development

Standardizing FDA Data to Improve Success in Pediatric Drug Development Paper RA01 Standardizing FDA Data to Improve Success in Pediatric Drug Development Case Study: Harmonizing Hypertensive Pediatric Data across Sponsors using SAS and the CDISC Model Julie Maddox, SAS Institute,

More information

SAS offers technology to facilitate working with CDISC standards : the metadata perspective.

SAS offers technology to facilitate working with CDISC standards : the metadata perspective. SAS offers technology to facilitate working with CDISC standards : the metadata perspective. Mark Lambrecht, PhD Principal Consultant, Life Sciences SAS Agenda SAS actively supports CDISC standards Tools

More information

Standard Safety Visualization Set-up Using Spotfire

Standard Safety Visualization Set-up Using Spotfire Paper SD08 Standard Safety Visualization Set-up Using Spotfire Michaela Mertes, F. Hoffmann-La Roche, Ltd., Basel, Switzerland ABSTRACT Stakeholders are requesting real-time access to clinical data to

More information

PhUSE Paper TT05

PhUSE Paper TT05 Paper TT05 Generating Analysis Results and Metadata report from a PhUSE CS project Marc Andersen, StatGroup ApS, Copenhagen, Denmark Marcelina Hungria, DIcore Group, LLC, NJ, USA Suhas R. Sanjee, Merck

More information

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences

Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 1 Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 2 Content Standards Technical Standards SDTM v1.1 SDTM IG v3.1.1

More information

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS

Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Agenda Introduction to the SAS Clinical Standards Toolkit (CST) Define-XML History and Background What is Define-XML?

More information

Optimization of the traceability when applying an ADaM Parallel Conversion Method

Optimization of the traceability when applying an ADaM Parallel Conversion Method SI04 Optimization of the traceability when applying an ADaM Parallel Conversion Method Roxane Debrus ADaM Conversion Process Agenda %LIB_QC_contents_html %adam_sdtm_compa Conclusion ADaM Conversion Process

More information

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.

One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc. One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc. Chapel Hill, NC RHelms@RhoWorld.com www.rhoworld.com Presented to ASA/JSM: San Francisco, August 2003 One-PROC-Away

More information

Streamline SDTM Development and QC

Streamline SDTM Development and QC Paper SI09 Streamline SDTM Development and QC Stephen Gormley, Amgen, United Kingdom ABSTRACT Amgen s Global Statistical Programming ( GSP ) function have one centralised team (The CDISC Consultancy and

More information

Advantages of a real end-to-end approach with CDISC standards

Advantages of a real end-to-end approach with CDISC standards Advantages of a real end-to-end approach with CDISC standards Dr. Philippe Verplancke CEO XClinical GmbH 26th Annual EuroMeeting 25-27 March 2014 ACV, Vienna Austria Disclaimer The views and opinions expressed

More information